Research 13F holdings and institutional ownership across 500+ asset managers
A directory of real use cases of people and companies using AI and AI agents in accounting, treasury, consolidation, annual accounts, controlling and reporting, and in the most widely used financial E
Stage
Not given
Not given
Founded
Not given
Not given
Based in
Not given
Not given
Pricing model
Freemium
Not given
Pricing
Monthly plan: $19.9/mo includes every quarter of history, full holders lists, 5,000 credits, and daily check-in +20 credits. Yearly plan: $169/yr (saves 29% vs monthly) includes all monthly features plus 60,000 credits and CSV export exclusive to yearly subscribers.
Not given
Key features
Quarterly 13F filings normalized from 500+ asset management companies
Co-holdings analysis showing which managers own the same securities
Reported position changes tracking increases and reductions
AMC Screener to browse asset management companies with holdings and portfolio value
AMC AI research assistant backed by 13F data
Industry exposure analysis by GICS sectors
Buy/Sell Trends to spot accumulation and distribution across managers
Watchlist to track favorite stocks and manager position changes
Side-by-side company comparison tool
CSV export capability on yearly subscription
Directory of real use cases with identified users
Tutorials for replicating use cases
Guides and manuals for setup and configuration
Ready-to-copy prompts with variables and warnings
Community resources including open tools and templates
Evidence levels for each entry
Coverage of 17 ERPs
Bilingual content in English and Spanish
What makes it different
Covers 556 asset managers with 105,788 holdings across 5,271 stocks
Data sourced directly from official SEC Form 13F filings without substitution or inference
AI-powered research assistant with never-expiring credits
Real, identifiable users rather than anonymous examples
Verified sources and public links for every entry
Clear confidence levels so announcements are not mistaken for results
Practical, tested approaches prioritized over press releases